Spyglass Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bright Horizons
BFAM
|
+$55.6M |
| 2 |
Five Below
FIVE
|
+$46.1M |
| 3 |
Lyft
LYFT
|
+$38.2M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$27.3M |
| 5 |
Palo Alto Networks
PANW
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanta Services
PWR
|
+$33.8M |
| 2 |
Advanced Micro Devices
AMD
|
+$27.8M |
| 3 |
IMAX
IMAX
|
+$13M |
| 4 |
DexCom
DXCM
|
+$10.4M |
| 5 |
EVBG
Everbridge, Inc. Common Stock
EVBG
|
+$3.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.86% |
| 2 | Consumer Discretionary | 21.34% |
| 3 | Healthcare | 15.8% |
| 4 | Communication Services | 8% |
| 5 | Real Estate | 5.26% |
Similar funds
Spyglass Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Spyglass Capital Management held 28 positions worth $885M, up 14% from $779M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Spyglass Capital Management deployed $340M of net new capital in Q1 2020, opening 3 new positions and adding to 19 existing holdings. Its largest new stake was Bright Horizons: 377,866 shares worth $38.5M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 43% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was DexCom, an estimated $10.4M trimmed.
- Spyglass Capital Management's largest Q1 2020 buy was Bright Horizons: 377,866 shares worth $38.5M.
- Spyglass Capital Management added most to Exact Sciences in Q1 2020, an estimated $27.3M increase.
- Spyglass Capital Management's biggest Q1 2020 reduction was DexCom, cutting an estimated $10.4M.
- Spyglass Capital Management fully exited Quanta Services in Q1 2020, selling an estimated $33.8M.
- Spyglass Capital Management's ten largest holdings make up 51% of its $885M portfolio in Q1 2020.
- Spyglass Capital Management opened 3 new positions and closed 3 in Q1 2020.
- Spyglass Capital Management's portfolio value rose 14% quarter-over-quarter to $885M.
Based on Spyglass Capital Management's 13F filing for Q1 2020, filed 15 May 2020.